Cardiovascular actions of trout urotensin II in the conscious trout, Oncorhynchus mykiss - PubMed (original) (raw)
Cardiovascular actions of trout urotensin II in the conscious trout, Oncorhynchus mykiss
J C Le Mevel et al. Am J Physiol. 1996 Nov.
Abstract
The central and peripheral cardiovascular effects of synthetic trout urotensin II (UII) were investigated in the conscious rainbow trout. Intracerebroventricular injection of 50 pmol UII produced a slight (3%) but significant (P < 0.05) increase in heart rate but had no effect on mean arterial blood pressure. Injection of 500 pmol UII icv produced a significant (P < 0.05) rise (8%) in blood pressure with no change in heart rate. In contrast to the weak pressor effect of centrally administered UII, intra-arterial injection of UII produced a dose-dependent increase in arterial blood pressure and decrease in heart rate with significant (P < 0.05) effects on both parameters observed at a dose of 25 pmol. Higher doses of the peptide produced a sustained decrease in cardiac output that accompanied the bradycardia and rise in arterial blood pressure. The UII-induced bradycardia, but not the increase in pressure, was abolished by pretreatment with phentolamine. Trout UII produced a sustained and dose-dependent contraction of isolated vascular rings prepared from trout efferent branchial [-log 50% of the concentration producing maximal contraction (pD2) = 8.30] and celiacomesenteric (pD2 = 8.22) arteries but was without effects on vascular rings from the anterior cardinal vein. The data indicate that the pressor effect of UII in trout is mediated predominantly, if not exclusively, by an increase in systemic vascular resistance. The UII-induced hypertensive response does not seem to involve release of catecholamines, but the bradycardia may arise from adrenergic-mediated activation of cardioinhibitory baroreflexes.
Similar articles
- Effects of peripherally administered urotensin II and arginine vasotocin on the QT interval of the electrocardiogram in trout.
Vanegas G, Lancien F, Leprince J, Vaudry H, Le Mével JC. Vanegas G, et al. Comp Biochem Physiol C Toxicol Pharmacol. 2016 May-Jun;183-184:53-60. doi: 10.1016/j.cbpc.2016.01.006. Epub 2016 Feb 21. Comp Biochem Physiol C Toxicol Pharmacol. 2016. PMID: 26902806 - Cardiovascular actions of centrally and peripherally administered trout urotensin-I in the trout.
Mimassi N, Shahbazi F, Jensen J, Mabin D, Conlon JM, Le Mével JC. Mimassi N, et al. Am J Physiol Regul Integr Comp Physiol. 2000 Aug;279(2):R484-91. doi: 10.1152/ajpregu.2000.279.2.R484. Am J Physiol Regul Integr Comp Physiol. 2000. PMID: 10938236 - Central effects of native urotensin II on motor activity, ventilatory movements, and heart rate in the trout Oncorhynchus mykiss.
Lancien F, Leprince J, Mimassi N, Mabin D, Vaudry H, Le Mével JC. Lancien F, et al. Brain Res. 2004 Oct 15;1023(2):167-74. doi: 10.1016/j.brainres.2004.07.008. Brain Res. 2004. PMID: 15374742 - Cardiovascular actions of the stress-related neurohormonal peptides, corticotropin-releasing factor and urotensin-I in the trout Oncorhynchus mykiss.
Le Mével JC, Mimassi N, Lancien F, Mabin D, Conlon JM. Le Mével JC, et al. Gen Comp Endocrinol. 2006 Mar;146(1):56-61. doi: 10.1016/j.ygcen.2005.11.007. Epub 2006 Jan 4. Gen Comp Endocrinol. 2006. PMID: 16386738 Review. - Central and peripheral cardiovascular, ventilatory, and motor effects of trout urotensin-II in the trout.
Le Mével JC, Lancien F, Mimassi N, Leprince J, Conlon JM, Vaudry H. Le Mével JC, et al. Peptides. 2008 May;29(5):830-7. doi: 10.1016/j.peptides.2007.06.020. Epub 2007 Jun 28. Peptides. 2008. PMID: 17681644 Review.
Cited by
- Urotensin II system in chronic kidney disease.
Michael OS, Kanthakumar P, Soni H, Rajesh Lenin R, Abhiram Jha K, Gangaraju R, Adebiyi A. Michael OS, et al. Curr Res Physiol. 2024 May 7;7:100126. doi: 10.1016/j.crphys.2024.100126. eCollection 2024. Curr Res Physiol. 2024. PMID: 38779598 Free PMC article. Review. - Acute Effect of Central Administration of Urotensin II on Baroreflex and Blood Pressure in Conscious Normotensive Rabbits.
Lim K, Sata Y, Jackson KL, Burke SL, Head GA. Lim K, et al. Front Physiol. 2017 Feb 23;8:110. doi: 10.3389/fphys.2017.00110. eCollection 2017. Front Physiol. 2017. PMID: 28280470 Free PMC article. - Central and Peripheral Effects of Urotensin II and Urotensin II-Related Peptides on Cardiac Baroreflex Sensitivity in Trout.
Lancien F, Vanegas G, Leprince J, Vaudry H, Le Mével JC. Lancien F, et al. Front Neurosci. 2017 Feb 10;11:51. doi: 10.3389/fnins.2017.00051. eCollection 2017. Front Neurosci. 2017. PMID: 28239335 Free PMC article. - Hollow-layered nanoparticles for therapeutic delivery of peptide prepared using electrospraying.
Rasekh M, Young C, Roldo M, Lancien F, Le Mével JC, Hafizi S, Ahmad Z, Barbu E, Gorecki D. Rasekh M, et al. J Mater Sci Mater Med. 2015 Nov;26(11):256. doi: 10.1007/s10856-015-5588-y. Epub 2015 Oct 8. J Mater Sci Mater Med. 2015. PMID: 26449446 - Divergent cardio-ventilatory and locomotor effects of centrally and peripherally administered urotensin II and urotensin II-related peptides in trout.
Vanegas G, Leprince J, Lancien F, Mimassi N, Vaudry H, Le Mével JC. Vanegas G, et al. Front Neurosci. 2015 Apr 22;9:142. doi: 10.3389/fnins.2015.00142. eCollection 2015. Front Neurosci. 2015. PMID: 25954149 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources